Risk assessments for SARS-CoV-2 variants. Category: UncategorisedBy 25 June 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Cervical screening pathway requirements specificationNextNext post:Research: Investigation of SARS-CoV-2 variants of concern: routine variant data update